Clinical trials
Active, not recruiting Phase 1/2 Carcinoma, Ovarian Epithelial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 23andMe, Inc. | 1 |
| Alexander B Olawaiye, MD | 1 |
| Case Comprehensive Cancer Center | 1 |
| Imunon | 1 |
| Klus Pharma Inc. | 1 |
| Salubris Biotherapeutics Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 6 |
| Small Cell Lung Carcinoma | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Transitional Cell | 2 |
| Fallopian Tube Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.